Skip to content
10-K/A

Annual Report

PHARMOS CORP

0001513160-12-000013

← back to feed
Filed
Feb 21, 2012 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Feb 17, 2012 60.02M sh
Operating Cash Flow FY 2011 · Dec 31, 2011 −$1.6M
Operating Cash Flow FY 2011 · Dec 31, 2010 −$1.48M
Cash And Equivalents FY 2011 · Dec 31, 2011 $1.54M
Cash And Equivalents FY 2011 · Dec 31, 2010 $3.14M
Cash And Equivalents FY 2011 · Dec 31, 2009 $4.63M
Stockholders Equity FY 2011 · Dec 31, 2011 $301.15K
Stockholders Equity FY 2011 · Dec 31, 2010 $2.02M
Current Liabilities FY 2011 · Dec 31, 2011 $1.36M
Current Liabilities FY 2011 · Dec 31, 2010 $171.11K
Total Liabilities FY 2011 · Dec 31, 2011 $1.36M
Total Liabilities FY 2011 · Dec 31, 2010 $1.17M
Current Assets FY 2011 · Dec 31, 2011 $1.66M
Current Assets FY 2011 · Dec 31, 2010 $3.19M
Total Assets FY 2011 · Dec 31, 2011 $1.66M
Total Assets FY 2011 · Dec 31, 2010 $3.19M
Sga Expense FY 2011 · Dec 31, 2011 $1.01M
Sga Expense FY 2011 · Dec 31, 2010 $1.19M
Rd Expense FY 2011 · Dec 31, 2011 $870.59K
Rd Expense FY 2011 · Dec 31, 2010 $497.94K
Net Income FY 2011 · Dec 31, 2011 −$1.98M
Net Income FY 2011 · Dec 31, 2010 −$1.55M
Operating Income FY 2011 · Dec 31, 2011 −$1.88M
Operating Income FY 2011 · Dec 31, 2010 −$1.44M